Jacob Zijlstra

Title: Jacob Zijlstra: Innovator in Antioxidant Research and DNA Sequencing

Introduction

Jacob Zijlstra is a notable inventor based in Coppet, Switzerland. He has made significant contributions to the fields of antioxidant research and DNA sequencing. With a total of 3 patents, Zijlstra's work has implications for medical treatments and genetic analysis.

Latest Patents

Zijlstra's latest patents include a synergistic antioxidant combination of delta tocols and polyphenols. This innovative combination acts synergistically to suppress LDL oxidation in serum, which has wide-ranging applications in treating medical conditions arising from free radical generation, including arteriosclerosis and cancer. Another significant patent is a method for the quantitative determination of DNA sequences. This method allows for the selective amplification of DNA sequences while eliminating any residual wild-type DNA sequences, enhancing the accuracy of genetic analysis.

Career Highlights

Throughout his career, Jacob Zijlstra has worked with prominent companies such as Behring Diagnostics GmbH and Nestec S.A. His experience in these organizations has contributed to his expertise in developing innovative solutions in his fields of interest.

Collaborations

Zijlstra has collaborated with notable professionals, including Peter Cerutti and Jeannette Whitcomb. These collaborations have further enriched his research and development efforts.

Conclusion

Jacob Zijlstra's contributions to antioxidant research and DNA sequencing highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to addressing critical health issues through scientific innovation.